Enoxaparin sodium/heparinMajor bleeding complications and lack of efficacy: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1935卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28993-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：198 / 198

相关论文

共 50 条

[31] Aspirin/warfarinGastrointestinal bleeding and lack of efficacy: 5 case reports
[J]. Reactions Weekly, 2021, 1851 (1) : 67 - 67
[32] Enoxaparin-sodium/heparinLack of efficacy and thrombocytopenia: 3 case reports
[J]. Reactions Weekly, 2022, 1887 (1) : 302 - 302
[33] RivaroxabanBleeding, major bleeding and lack of efficacy: 5 case reports
[J]. Reactions Weekly, 2023, 1942 (1) : 252 - 252
[34] Apixaban/rivaroxabanGI bleeding, retroperitoneal bleeding and lack of efficacy: 4 case reports
[J]. Reactions Weekly, 2019, 1735 (1) : 44 - 44
[35] Enoxaparin-sodium/rivaroxabanLack of efficacy and menorrhagia: 2 case reports
[J]. Reactions Weekly, 2022, 1906 (1) : 185 - 185
[36] Abemaciclib/aspirin/enoxaparin sodiumVarious toxicities and lack of efficacy: 4 case reports
[J]. Reactions Weekly, 2022, 1925 (1) : 15 - 15
[37] Enoxaparin-sodium/anticoagulantsAbdominal skin ecchymosis, heparin-induced thrombocytopenia and lack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1959 (1) : 266 - 266
[38] Dabigatran-etexilate/idarucizumabBleeding and thrombotic complications, and lack of efficacy to idarucizumab: 7 case reports
[J]. Reactions Weekly, 2019, 1750 (1) : 98 - 98
[39] Multiple drugsHypersensitivity and lack of efficacy: 7 case reports
[J]. Reactions Weekly, 2022, 1922 (1) : 407 - 407
[40] Antibacterials/bevacizumabEndophthalmitis and lack of efficacy: 7 case reports
[J]. Reactions Weekly, 2022, 1931 (1) : 51 - 51

← 1 2 3 4 5 →